Skip to content
The Policy VaultThe Policy Vault

alpelisib (PROS)Blue Cross Blue Shield of Illinois

off-label or other uses (Fully Insured or HIM Shop Ohio members)

Initial criteria

  • ALL of the following:
  • 1. Member resides in Ohio AND
  • 2. Plan is Fully Insured or HIM Shop (SG) AND BOTH of:
  • A. Patient does NOT have any FDA labeled contraindications to the requested agent AND
  • B. ONE of the following:
  • 1. Patient has another FDA labeled indication for the requested agent and route of administration OR
  • 2. Patient has another indication supported in compendia for the requested agent and route of administration OR
  • 3. Prescriber has submitted TWO articles from major peer-reviewed professional medical journals (e.g., JAMA, NEJM, Lancet) supporting the proposed use as generally safe and effective [case studies not acceptable]
  • Compendia accepted:
  • Non-oncology: DrugDex level 1, 2A, or 2B; AHFS-DI (supportive narrative)
  • Oncology: NCCN 1 or 2A; AHFS-DI (supportive narrative); DrugDex level 1, 2A, or 2B; Clinical Pharmacology (supportive narrative); LexiDrugs level A; peer-reviewed medical literature

Approval duration

12 months